638 related articles for article (PubMed ID: 20733159)
21. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
22. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
[TBL] [Abstract][Full Text] [Related]
23. CD56
Kobyzeva PA; Streltsova MA; Erokhina SA; Kanevskiy LM; Telford WG; Sapozhnikov AM; Kovalenko EI
J Leukoc Biol; 2020 Oct; 108(4):1379-1395. PubMed ID: 32930385
[TBL] [Abstract][Full Text] [Related]
24. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
25. Proteome analysis of distinct developmental stages of human natural killer (NK) cells.
Scheiter M; Lau U; van Ham M; Bulitta B; Gröbe L; Garritsen H; Klawonn F; König S; Jänsch L
Mol Cell Proteomics; 2013 May; 12(5):1099-114. PubMed ID: 23315794
[TBL] [Abstract][Full Text] [Related]
26. [Expression and function of killer immunologublin receptor and CD57 of natural killer cells].
Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):115-9. PubMed ID: 24535362
[TBL] [Abstract][Full Text] [Related]
27. The biology of human natural killer-cell subsets.
Cooper MA; Fehniger TA; Caligiuri MA
Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
[TBL] [Abstract][Full Text] [Related]
28. Increased Frequency of Dysfunctional Siglec-7
Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
Front Immunol; 2021; 12():603133. PubMed ID: 33692781
[TBL] [Abstract][Full Text] [Related]
29. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
[TBL] [Abstract][Full Text] [Related]
30. Skewed distribution of natural killer cells in psoriasis skin lesions.
Batista MD; Ho EL; Kuebler PJ; Milush JM; Lanier LL; Kallas EG; York VA; Chang D; Liao W; Unemori P; Leslie KS; Maurer T; Nixon DF
Exp Dermatol; 2013 Jan; 22(1):64-6. PubMed ID: 23278897
[TBL] [Abstract][Full Text] [Related]
31. CD57 in human natural killer cells and T-lymphocytes.
Kared H; Martelli S; Ng TP; Pender SL; Larbi A
Cancer Immunol Immunother; 2016 Apr; 65(4):441-52. PubMed ID: 26850637
[TBL] [Abstract][Full Text] [Related]
32. Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.
Dowell AC; Oldham KA; Bhatt RI; Lee SP; Searle PF
Cancer Immunol Immunother; 2012 May; 61(5):615-28. PubMed ID: 22021067
[TBL] [Abstract][Full Text] [Related]
33. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C
Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160
[TBL] [Abstract][Full Text] [Related]
34. Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates.
Musha N; Yoshida Y; Sugahara S; Yamagiwa S; Koya T; Watanabe H; Hatakeyama K; Abo T
Clin Exp Immunol; 1998 Aug; 113(2):220-8. PubMed ID: 9717971
[TBL] [Abstract][Full Text] [Related]
35. Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients.
Ali TH; Pisanti S; Ciaglia E; Mortarini R; Anichini A; Garofalo C; Tallerico R; Santinami M; Gulletta E; Ietto C; Galgani M; Matarese G; Bifulco M; Ferrone S; Colucci F; Moretta A; Kärre K; Carbone E
Nat Commun; 2014 Dec; 5():5639. PubMed ID: 25472612
[TBL] [Abstract][Full Text] [Related]
36. Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
Yao D; Xu L; Liu L; Zeng X; Zhong J; Lai J; Zheng R; Jin Z; Chen S; Zha X; Huang X; Lu Y
Biomed Res Int; 2020; 2020():9531549. PubMed ID: 33102599
[TBL] [Abstract][Full Text] [Related]
37. CD56(dim)CD16⁻ NK cell phenotype can be induced by cryopreservation.
Lugthart G; van Ostaijen-ten Dam MM; van Tol MJ; Lankester AC; Schilham MW
Blood; 2015 Mar; 125(11):1842-3. PubMed ID: 25766566
[No Abstract] [Full Text] [Related]
38. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.
Ferlazzo G; Pack M; Thomas D; Paludan C; Schmid D; Strowig T; Bougras G; Muller WA; Moretta L; Münz C
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16606-11. PubMed ID: 15536127
[TBL] [Abstract][Full Text] [Related]
40. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
Fan YY; Yang BY; Wu CY
Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
